We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
2023 update on Italian guidelines for the treatment of type 2 diabetes.
- Authors
Mannucci, Edoardo; Candido, Riccardo; Monache, Lina delle; Gallo, Marco; Giaccari, Andrea; Masini, Maria Luisa; Mazzone, Angela; Medea, Gerardo; Pintaudi, Basilio; Targher, Giovanni; Trento, Marina; Turchetti, Giuseppe; Lorenzoni, Valentina; Monami, Matteo
- Abstract
B 5.3 Glucose-lowering therapy in patients with type 2 diabetes and previous cardiovascular events without heart failure b Which glucose-lowering agents should be considered as first-, second-, and third-line therapies for glycemic control in patients with type 2 diabetes and previous cardiovascular events and without heart failure? B 5.6 Choice of long-acting basal insulin b Question: Should long-acting basal insulin with longer duration (glargine U300 and degludec) be preferred to long-acting basal insulin with shorter duration (detemir and glargine U100) in patients with type 2 diabetes needing treatment with basal insulin? B 4.2 Group- and individual-based educational therapy b Question: Should group-based educational therapy be preferable in comparison with individual therapy for diabetes control in patients with type 2 diabetes? PHARMACOLOGICAL THERAPY b B 5.1 Glucose-lowering therapy in patients with type 2 diabetes and no previous cardiovascular events or chronic renal failure b Which glucose-lowering agents should be considered as first-, second-, and third-line therapies for glycemic control in patients with type 2 diabetes and no previous cardiovascular events or chronic renal failure? B 5.4 Glucose-lowering therapy in patients with type 2 diabetes and heart failure b Which glucose-lowering agents should be considered as first-, second-, and third-line therapies for glycemic control in patients with type 2 diabetes and heart failure?.
- Subjects
SUBCUTANEOUS infusions; AEROBIC exercises; TYPE 2 diabetes; INSULIN derivatives; INSULIN; DIET therapy
- Publication
Acta Diabetologica, 2023, Vol 60, Issue 8, p1119
- ISSN
0940-5429
- Publication type
Article
- DOI
10.1007/s00592-023-02107-x